Amyloidogenicity assessment of transthyretin gene variants

OBJECTIVE: Hereditary transthyretin‐mediated amyloidosis is a treatable condition caused by amyloidogenic variants in the transthyretin‐gene resulting in severe peripheral neuropathy or cardiomyopathy. Only about a third of over 130 known variants are clearly pathogenic, most are classified as varia...

Descripción completa

Detalles Bibliográficos
Autores principales: Grether, Nicolai B., Napravnik, Felix, Imhof, Thomas, Linke, Reinhold P., Bräsen, Jan H., Schmitz, Jessica, Dohrn, Maike, Schneider, Christian, Svačina, Martin K. R., Stetefeld, Jörg, Koch, Manuel, Lehmann, Helmar C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380149/
https://www.ncbi.nlm.nih.gov/pubmed/35903975
http://dx.doi.org/10.1002/acn3.51626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380149/
https://www.ncbi.nlm.nih.gov/pubmed/35903975
http://dx.doi.org/10.1002/acn3.51626

Ejemplares similares